Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1056_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Contents
- •About the Editors
- •Contributors
- •3 Host Factors: Age, Gender, Lifestyle
- •4 IBD and Other Etiologically Relevant Comorbid Conditions
- •5 Anatomical Presentation and Rectovaginal Fistula
- •6 Anal Fistula Development: Microbiological Factors
- •7 Recurrence and Cancer Risk
- •8 Conclusion
- •References
- •1 Epidemiology of Anal Fistula and Abscess
- •1 Introduction
- •2 Incidence and Prevalence
- •2.1 Europe
- •2.2 USA and Canada
- •2 Anorectal Anatomy Related to Anal Fistula and Abscess
- •1 Introduction
- •2 Mucosal Layer and Submucosal Space
- •3 Internal Anal Sphincter
- •4 Intersphincteric Space and Conjoint Longitudinal Muscle
- •5 External Anal Sphincter
- •6 Pelvic Floor
- •7 Extra-anal Spaces/Ischioanal Fossae
- •8 Anal Glands
- •10 Conclusion
- •11 Cross-References
- •References
- •3 Anorectal Physiology Related to Anal Fistula and Abscess
- •1 Principal Aspects of Anorectal Physiology
- •1.1 Secretory Function of the Anorectum and the Cryptoglandular Hypothesis
- •1.2 Histology and Cellular Physiology of the Anorectum and Fistula
- •1.3 Microbiology and Fistula
- •1.4 Host Factors Relevant to Abscess and Fistula
- •1.5 Anal Continence
- •1.5.1 The Rectum
- •1.5.2 The Musculature of the Pelvic Floor and Sphincter Complex
- •1.6 Defecation
- •1.7 Anorectal Physiology Testing in the Context of Fistula
- •1.7.2 Perioperative Anorectal Physiology Testing
- •2 Conclusion
- •References
- •4 Unconventional Insights in the Pathogenesis and Etiology of Fistulas in the Perianal Region
- •1 Introduction
- •1.1 Etiology
- •1.2 Risk Factors for Development of Perianal Fistula
- •1.3 Risk Factors due to the Type of Perianal Fistula
- •1.4 Treatment-Related Risk Factors for Failure
- •1.5 Preliminary Conclusions
- •2.1 Anatomy of the Anal Canal
- •2.2 Histology of the Anal Canal
- •2.3 Histopathologic Concepts of Perianal Fistulas
- •3.1 Old Stories, New Histopathological Concepts?
- •3.2 Old Stories, New Clinical Concepts?
- •3.2.1 Basic Concepts
- •3.3 Based on Previous Medical History
- •3.4 Aspect and Localization of the Fistula Opening
- •3.5 Phenotype 1
- •3.6 Phenotype 2
- •3.7 Phenotype 3
- •3.8 Phenotype 4
- •3.9 Phenotype 5
- •4 Discussion and Conclusions
- •5 Cross-References
- •References
- •5 From Abscess to Fistula
- •1 Anorectal Abscess
- •References
- •6 Classification of Anal Fistula and Abscess
- •1 Introduction
- •2 Purpose and Attributes of a Classification
- •3 Overview of Anal Fistula Classifications
- •4 Anal Fistula Classifications
- •4.1 Parks Classification
- •4.1.1 Strong Points
- •4.1.2 Weak Points
- •5.1 Strong Points
- •5.2 Weak Points
- •6 Garg Classification
- •6.6 Strong Points
- •6.7 Weak Points
- •7 Status of Extrasphincteric Fistulas
- •8 Evaluation of Existing Classifications on Long-Term Data
- •9 Conclusions
- •References
- •7 Clinical Assessment of Anal Cryptoglandular Abscess and Fistula
- •1 Introduction
- •2 Types of Clinical Evaluation
- •3 Diagnosis
- •4 Topographic Evaluation
- •4.1 The Cryptic Endoanal Primary Opening
- •4.2 The Secondary Opening or Openings
- •4.3 The Main Tract of the Fistula
- •4.4 Possible Purulent Collections
- •1.1 Physical Examination of the Anus and Rectum: General Principles
- •4.5 Possible Secondary Extensions
- •5 Conclusion
- •References
- •8 Clinical Assessment of Crohn Perianal Abscesses and Fistulas
- •1 Introduction
- •1.2 Inspection
- •1.3 Palpation
- •1.4 Endoscopy
- •2 Clinical Presentation
- •2.1 Skin Lesions
- •2.2 Fistulas
- •2.3 Abscesses
- •2.4 Diagnostic Workup
- •2.4.1 General Principles
- •2.5 US
- •2.6 Effectiveness and Sensitivity
- •2.6.1 Endoscopy
- •2.7 MRI
- •2.7.1 CT Scan
- •2.7.2 Fistulography
- •2.8 Diagnostic Follow-up
- •References
- •9 Anorectal Physiology Assessment in Patients with Anal Fistula: When Necessary
- •1 Introduction
- •2 Anorectal Physiology Assessment
- •2.1 Anamnesis
- •2.2 Physical Examination
- •2.3 Anorectal Manometry
- •2.3.1 Equipment
- •2.3.2 Manometry Systems
- •2.4 Neurophysiologic Tests
- •2.4.1 Electromyography
- •2.4.2 Nerve Conduction Studies
- •2.5 Endoanal Ultrasound
- •2.6 Role of Anorectal Physiology Patterns in the Decision-Making
- •3 Discussion
- •References
- •1 Introduction
- •2 Anal Anatomy
- •3 Classification of Fistulas
- •4 EAUS Imaging
- •4.1 Probes EAUS
- •4.2 Performing EAUS
- •4.3 EUS in Perianal Fistulas
- •4.4 Adding Hydrogen Peroxide (H2O2)
- •4.5 Cryptoglandular Fistulas
- •5 Comparison with Other Diagnostic Modalities
- •5.1 Comparison with Surgery
- •5.2 Comparison with MRI
- •5.3 Perineal Ultrasound
- •6 Conclusion and Recommendation
- •References
- •1 Introduction
- •2 Imaging
- •2.1 Conventional Contrast Material-Enhanced Fistulography
- •2.2 CT
- •2.3 Magnetic Resonance Imaging
- •2.3.1 Anatomy MRI
- •2.3.2 MRI Technique (Coils, Volume, and Sequences) and Findings
- •2.3.3 MRI Reconstruction Techniques and Fistulography MRI
- •2.3.4 Internal and Cutaneous Opening
- •2.3.5 Classifications of Perianal Fistulas and Abscesses
- •2.3.6 Deep Posterior Anal Fistulas and Abscess
- •2.3.7 MRI Report
- •2.3.9 MR Role in the Evaluation of the Crypto-Glandular Fistulas
- •3 Conclusion
- •4 Cross-References
- •References
- •1 Introduction
- •2 Clinical Presentation
- •3 Utility and Limitations of Endoanal Ultrasound
- •4 Conclusion
- •5 Cross-References
- •References
- •1 Introduction
- •2 Imaging
- •3 Diagnosis
- •4 MRI Technique
- •5 Disease Monitoring
- •6 Future Directions
- •7 Conclusion
- •8 Cross-References
- •References
- •14 Future Perspectives in the Diagnosis of Anal Fistula and Abscess
- •1 Introduction
- •2 Assessment of Abscess and Anal Fistula
- •3 Abscess
- •3.1 Computed Tomography (CT)
- •3.2 Magnetic Resonance Imaging (MRI)
- •3.3 Endoanal Ultrasound
- •3.4 Transperineal Ultrasonography (TP-US)
- •4 Anal Fistula
- •4.1 Imaging
- •4.1.1 Endoanal Ultrasound
- •4.1.2 Magnetic Resonance Imaging
- •5 Conclusion
- •6 Cross-References
- •References
- •15 How to Drain an Abscess
- •1 Introduction
- •2 Epidemiology and Etiology
- •3 Classification
- •4 Clinical Manifestations and Diagnosis
- •5 Management
- •7 Wound Dressing
- •8 Microbiology and Antibiotics
- •9 General Postoperative Management
- •10 Conclusion
- •11 Cross-References
- •References
- •16 The Seton in Anal Fistula Management
- •1 Introduction
- •2 2500 Years of Setons
- •3 To Put or Not to Put
- •4 To Cut or Not to Cut
- •5 What Kind of Seton to Use?
- •7 Seton 2.0: New Perspectives
- •8 Uncomfortable Questions (How to Do It)
- •9 What Patients Should Know
- •10 Conclusions: Seton in Guidelines
- •References
- •17 Fistulotomy
- •1 Introduction
- •2 Indications
- •3 Fistulotomy: Standard Technique
- •4 Other Fistulotomy Techniques
- •4.1 Addition of Loose Seton
- •4.2 Slow Dissection of the Sphincter: Cutting Seton
- •4.3 Addition of Marsupialization
- •5 Fistulotomy with Immediate Primary Sphincteroplasty (FIPS)
- •7 Postoperative Care
- •8 Complications and Recurrence Rate
- •9 Discussion
- •10 Conclusion
- •References
- •18 Fistulectomy
- •1 Introduction
- •2 Preoperative Evaluation
- •2.1 Patient Selection
- •2.2 Imaging
- •2.3 Physiologic Testing
- •2.4 Endoscopic Examination
- •3 Technique
- •3.1 Patient Preparation
- •3.2 Patient Positioning
- •3.2.1 Technical Steps
- •4 Postoperative Care
- •5 Results
- •5.1 Fistulectomy
- •6 Fistulectomy with Sphincter Reconstruction
- •7 Conclusions
- •References
- •19 Utility of Adding Sphincter Reconstruction to Fistulotomy/Fistulectomy
- •1 Introduction
- •2 General Classification
- •3 Preoperative Preparation
- •4 Surgical Technique Step by Step
- •5 Results
- •6 Conclusion
- •7 Cross-References
- •References
- •20 Utility of Marsupialization Following Anal Fistula Surgery
- •1 Introduction
- •2 Marsupialization
- •3 Clinical Evidence
- •4 Conclusion
- •References
- •21 Transanal Advancement Flap Repair
- •1 Introduction
- •2 Nomenclature
- •3 Effectiveness of the Technique
- •4 Effectiveness of Repeat Procedures
- •5 Impact on Fecal Continence
- •6 Severity of Incontinence
- •7 Perioperative Care
- •7.1 Bowel Preparation
- •7.2 Antibiotic Prophylaxis
- •7.3 Prolonged Antibiotic Therapy
- •7.4 Type of Anesthesia
- •7.5 Immobilization
- •7.6 Bowel Confinement
- •7.7 Stool Softeners
- •7.8 Position
- •8 Aspects of Surgical Technique
- •8.1 Preoperative Care
- •8.2 Step 1
- •8.3 Step 2
- •8.4 Step 3
- •8.5 Step 4
- •8.6 Step 5
- •8.7 Postoperative Care
- •8.8 Types of Flap
- •8.9 Shape of Flap
- •8.10 Thickness of Flap
- •8.11 Addition of Accessory Techniques
- •9 Necessity of Preoperative Imaging
- •10 Factors Contributing to Successful Healing
- •10.1 Fistula-Related Factors
- •10.2 Patient-Related Factors
- •10.3 Influence of Covering Ostomy
- •10.4 Impact of the Use of Draining Setons
- •11 Conclusion
- •References
- •22 Dermal Flap Anoplasty for Trans-sphincteric Anal Fistula
- •1 Rationale
- •2 Technique
- •3 Other Dermal Flaps
- •4 Discussion
- •5 Cross-References
- •References
- •23 (LIFT) Ligation of Intersphincteric Fistula Tract
- •References
- •24 Anal Fistula: Glue and Paste Injection
- •1 Introduction
- •2 Fibrin Glue
- •3 Collagen Paste
- •4 Conclusion
- •5 Cross-References
- •References
- •25 VAAFT
- •1 Introduction
- •1.1 VAAFT Story
- •2 Surgical Equipment and Accessories
- •3 VAAFT Indications
- •3.1 Preoperative Assessment
- •4 VAAFT Procedure
- •4.1 Diagnostic Phase (Fistuloscopy)
- •4.2 Operative Phase
- •5 Closure of the Internal Opening
- •5.1 Use of a Linear or Semicircular Stapler
- •5.2 Advancement Flap
- •5.3 Use of a Bioabsorbable Mesh (Xenograft)
- •5.4 Autologous Dermis Graft
- •5.4.1 VAAFT Associated to the LIFT Procedure
- •5.5 Postoperative Management
- •6 Discussion
- •7 Conclusions
- •References
- •26 The Laser Treatment of Anal Fistulas
- •1 Introduction
- •1.1 Literature Review
- •1.3 Diagnosis and Treatment of Complex Anal Fistulas
- •2 Materials and Methods
- •3 Conclusion
- •References
- •27 Treatment by Over-the-Scope-Clip
- •1 Introduction
- •2 Technical Background
- •3 Surgical Application
- •4 Principle of Action
- •5 Clinical Data
- •References
- •28 Stem Cells in Cryptoglandular Anal Fistulas
- •1 Introduction
- •2 History of a Novel Approach
- •2.1 Mesenchymal Stem Cells
- •2.2 Adipose Tissue: The Ideal MSCs Source
- •2.3 Adipose Tissue Graft
- •2.3.1 Lipogems
- •3 Results
- •3.1 Literature Review
- •3.2 Personal Experience
- •4 Discussion and Conclusion
- •References
- •1 Introduction
- •2 Perianal and Rectovaginal Fistulas
- •2.1 Epidemiology and Diagnosis
- •2.2 Classification
- •2.3 Treatment Modalities
- •3 Flap Reconstruction
- •3.1 Overview and Considerations for Flap Reconstruction
- •4 Gracilis Interposition Flap
- •4.1 Background and Indications
- •4.2 Operative Technique
- •4.3 Results/Complications
- •5 Martius Interposition Flap
- •5.1 History and Indications
- •5.2 Surgical Technique
- •5.3 Results/Complications
- •6 Gluteal Muscle Interposition Flap
- •6.1 History and Indications
- •6.2 Surgical Technique
- •6.3 Results/Complications
- •7 Conclusion
- •References
- •30 Quality of Life Following Anal Fistula Treatment
- •1 Introduction
- •2 Quality of Life with an Anal Fistula
- •2.1 Cryptoglandular Fistulas
- •2.3 Conclusion
- •3 Quality of Life with a Seton and a Fistula

468 G. Naldini et al.
García-Aguilar J, Davey CS, Le CT, Lowry AC, Rothenberger DA (2000) Patient satisfaction after
surgical treatment for fistula-in-ano. Dis Colon Rectum 43(9):1206–12. https://doi.org/10.1007/
BF02237422. PMID: 11005484
Garcia-Arranz M, Garcia-Olmo D, Herreros MD, Gracia-Solana J, Guadalajara H, de la Portilla F,
... Prosper F (2020) Autologous adipose-derived stem cells for the treatment of complex
cryptoglandular perianal fistula: A randomized clinical trial with long-term follow-up. Stem
Cells Transl Med 9(3):295–301. https://doi.org/10.1002/sctm.19-0271
García-Olmo D, García-Arranz M, Gómez García L, Cuellar ES, Blanco IF, Prianes LA, ... García-
Sancho L (2003) Autologous stem cell transplantation for treatment of rectovaginal fistula in
perinatal Crohn’s disease: a new cell-based therapy. Int J Color Dis 18(5):451–454. https://doi.
org/10.1007/s00384-003-0490-3
Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, ... Pascual M (2009)
Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II
clinical trial. Dis Colon Rectum 52(1):79–86. https://doi.org/10.1007/DCR.0b013e3181973487
García-Olmo D, Van Assche G, Tagarro I, Diez MC, Richard MP, Khalid JM, ... Panés J (2019)
Prevalence of anal fistulas in Europe: systematic literature reviews and population-based
database analysis. Adv Ther 36(12):3503–3518. https://doi.org/10.1007/s12325-019-01117-y
Georgiev-Hristov T, Guadalajara H, Herreros MD, Lightner AL, Dozois EJ, García-Arranz M,
García-Olmo D (2018) A Step-By-Step Surgical Protocol for the Treatment of Perianal Fistula
with Adipose-Derived Mesenchymal Stem Cells. J Gastrointest Surg 22(11):2003-2012. https://
doi.org/10.1007/s11605-018-3895-6. Epub 2018 Jul 31. PMID: 30066070
Goujon E (1869) J de L’Anat et de La Physiol (6):399–412
Guadalajara H, Herreros D, De-La-Quintana P, Trebol J, Garcia-Arranz M, Garcia-Olmo D (2012)
Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to
treat complex perianal fistulas. Int J Color Dis 27(5):595–600. https://doi.org/10.1007/s00384-
011-1350-1
Hass R, Kasper C, Böhm S, Jacobs R (2011) Different populations and sources of human
mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell
Commun Signal 9. https://doi.org/10.1186/1478-811X-9-12
Herreros MD, Garcia-Arranz M, Guadalajara H, De-La-Quintana P, Garcia-Olmo D (2012) Autol-
ogous expanded adipose-derived stem cells for the treatment of complex cryptoglandular
perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula advanced therapy trial
1) and long-term evaluation. Dis Colon Rectum 55(7):762–772. https://doi.org/10.1097/DCR.
0b013e318255364a
Herreros MD, Garcia-Olmo D, Guadalajara H, Georgiev-Hristov T, Brandariz L, Garcia-Arranz M
(2019) Stem cell therapy: A compassionate use program in perianal fistula. Stem Cells Int.
https://doi.org/10.1155/2019/6132340. PMID: 31191678; PMCID: PMC6525789
Illouz YG (1983) Body contouring by lipolysis: a 5-year experience with over 3000 cases. Plast
Reconstr Surg 72(5):591–597. https://doi.org/10.1097/00006534-198311000-00001
Kontovounisios C, Tekkis P, Tan E, Rasheed S, Darzi A, Wexner SD (2016) Adoption and success
rates of perineal procedures for fistula-in-ano: a systematic review. Color Dis 18(5):441
https://doi.org/10.1111/codi.13330
Kotze PG, Spinelli A, Warusavitarne J, Di Candido F, Sahnan K, Adegbola SO, Danese S (2019)
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn’s disease. Drugs
Today 55(2):95–105. https://doi.org/10.1358/dot.2019.55.2.2914336
Laureti S, Gionchetti P, Cappelli A, Vittori L, Contedini F, Rizzello F, ... Poggioli G (2020)
Refractory complex Crohn’s perianal fistulas: a role for autologous microfragmented adipose
tissue injection. Inflamm Bowel Dis 26(2):321–330. https://doi.org/10.1093/ibd/izz051
Lazarus HM, Haynesworth SE, Gerson SL, Caplan AI (1997) Human bone marrow-derived
mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood
progenitor cell collections. J Hematother Stem Cell Res 6(5):447–455. https://doi.org/10.1089/
scd.1.1997.6.447
–458.

28 Stem Cells in Cryptoglandular Anal Fistulas 469
Lunniss PJ, Kamm MA, Phillips RKS (1994) Factors affecting continence after surgery for anal
fistula. Br J Surg 81(9):1382–1385. https://doi.org/10.1002/bjs.1800810947
Majumdar M, Thiede M, Mosca J, Moorman M, Gerson SL (1998) Phenotypic and functional
comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells.
J Cell Physiol 176(1). https://doi.org/10.1002/(SICI)1097-4652(199807)176:1<57::AID-
JCP7>3.0.CO;2-7
Mestak O, Sukop A, Hsueh YS, Molitor M, Mestak J, Matejovska J, Zarubova L (2014) Centrifu-
gation versus PureGraft for fatgrafting to the breast after breast-conserving therapy. World
J Surg Oncol 12(1). https://doi.org/10.1186/1477-7819-12-178
Naldini G, Sturiale A, Fabiani B, Giani I, Menconi C (2018) Micro-fragmented adipose tissue
injection for the treatment of complex anal fistula: a pilot study accessing safety and feasibility.
Tech Coloproctol. https://doi.org/10.1007/s10151-018-1755-8
Narang SK, Keogh K, Alam NN, Pathak S, Daniels IR, Smart NJ (2017) A systematic review of
new treatments for cryptoglandular fistula in ano. Surgeon 15(1):30–39. https://doi.org/10.1016/
j.surge.2016.02.002
Nava S, Sordi V, Pascucci L, Tremolada C, Ciusani E, Zeira O, ... Alessandri G (2019) Long-
lasting anti-inflammatory activity of human microfragmented adipose tissue. Stem Cells Int, 1–
13. https://doi.org/10.1155/2019/5901479
Parks AG, Gordon PH, Hardcastle JD (1976) A classification of fistula-in-ano. Br J Surg 63(1):1–
12. https://doi.org/10.1002/bjs.1800630102
Regulation(EC) No. 1394/2007 of the European Parliament and of the Council (n.d.). Retrievedfrom
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri¼OJ:L:2007:324:0121:0137:en:PDF
Ren H, Sang Y, Zhang F, Liu Z, Qi N, Chen Y (2016) Comparative analysis of human mesenchymal
stem cells from umbilical cord, dental pulp, and menstrual blood as sources for cell therapy.
Stem Cells Int. https://doi.org/10.1155/2016/3516574
Sainio P (1984) Fistula-in-ano in a defined population. Incidence and epidemiological aspects. Ann
Chir Gynaecol 73(4):219–224
Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB (2003) American gastroenterological associa-
tion technical review on perianal Crohn’s disease. Gastroenterology 125(5):1508–1530. https://
doi.org/10.1053/S0016-5085(03)01367-2
Stolzing A, Jones E, McGonagle D, Scutt A (2008) Age-related changes in human bone marrow-
derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 129(3):
163–173. https://doi.org/10.1016/j.mad.2007.12.002
Strem BM, Hicok KC, Zhu M, Wulur I, Alfonso Z, Schreiber RE, ... Hedrick MH (2005)
Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 54:132–141.
https://doi.org/10.2302/kjm.54.132
Taha AA, Tahseen H (2020) Spreading awareness. Plast Reconstr Surg – Glob Open 8(3):e2715.
https://doi.org/10.1097/gox.0000000000002715
Tavassoli M, Crosby WH (1968) Transplantation marrow. Science 161(3836):54–56
Vangsness CT, Sternberg H, Harris L (2015) Umbilical cord tissue offers the greatest number of
harvestable mesenchymal stem cells for research and clinical application: a literature review of
different harvest sites. Arthroscopy – J Arthrosc Related Surg 31:1836–1843. https://doi.org/10.
1016/j.arthro.2015.03.014
Von Heimburg D, Hemmrich K, Haydarlioglu S, Staiger H, Pallua N (2004) Comparison of viable
cell yield from excised versus aspirated adipose tissue. Cells Tissues Organs 178(2):87
https://doi.org/10.1159/000081719
Zakine G, Baruch J, Dardour JC, Flageul G (2015) Perforation of viscera, a dramatic complication
of liposuction: a review of 19 cases evaluated by experts in France between 2000 and 2012. Plast
Reconstr Surg 135(3):743–750. https://doi.org/10.1097/PRS.0000000000001030
Zanotti C, Martinez-Puente C, Pascual I, Pascual M, Herreros D, García-Olmo D (2007) An
assessment of the incidence of fistula-in-ano in four countries of the European Union. Int
J Color Dis 22(12):1459–1462. https://doi.org/10.1007/s00384-007-0334-7
–92.

470 G. Naldini et al.
Zhao RC (2013) Essentials of mesenchymal stem cell biology and its clinical translation. In:
Essentials of mesenchymal stem cell biology and its clinical translation, pp 1–313. https://doi.
org/10.1007/978-94-007-6716-4
Zhou C, Li M, Zhang Y, Ni M, Wang Y, Xu D, Shi Y, Zhang B, Chen Y, Huang Y, Zhang S, Shi H,
Jiang B (2020) Autologous adipose-derived stem cells for the treatment of Crohn’s fistula-in-
ano: an open-label, controlled trial. Stem Cell Res Ther 11(1):124. https://doi.org/10.1186/
s13287-020-01636-4. PMID: 32183875; PMCID: PMC7079384
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, ... Hedrick MH (2001) Multilineage
cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7(2):211–
228. https://doi.org/10.1089/107632701300062859
Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, ... Hedrick MH (2002) Human
adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13(12):4279–4295. https://
doi.org/10.1091/mbc.E02-02-0105

Additional Surgical Options to Treat Anal
Fistulas: Gracilis Interposition, Martius Flap,
29
and Gluteal Flap
Douglas Morte, Jace Franko, and Scott R. Steele
Contents
1 Introduction . ............... .................................................................. 472
2 Perianal and Rectovaginal Fistulas ......................................................... 473
2.1 Epidemiology and Diagnosis ......................................................... 473
2.2 Classification .................. .................................. ...................... 475
2.3 Treatment Modalities . . ................................................................ 476
3 Flap Reconstruction .... ....................................... .............................. 478
3.1 Overview and Considerations for Flap Reconstruction .............................. 478
4 Gracilis Interposition Flap ................................................................... 481
4.1 Background and Indications .......................................................... 481
4.2 Operative Technique .................................................................. 481
4.3 Results/Complications ................................................................. 483
5 Martius Interposition Flap . .................................................................. 484
5.1 History and Indications ............................................................... 484
5.2 Surgical Technique ..... . . . . ...... . . . . ...... . . . ....... . . . ...... . . . . ...... . . . . ...... . . . . 484
5.3 Results/Complications ................................................................. 487
6 Gluteal Muscle Interposition Flap .......................................................... 488
6.1 History and Indications ............................................................... 488
6.2 Surgical Technique ..... . . . . ...... . . . . ...... . . . ....... . . . ...... . . . . ...... . . . . ...... . . . . 488
6.3 Results/Complications ................................................................. 489
7 Conclusion ................................................................................... 490
References ............................ ............................................... ............ 491
Abstract
Anal fistulas are a common, but often difficult, disease process for the colorectal
and general surgeon to treat. Fistulas generally develop following
cryptoglandular infection of the anal canal that results in anorectal abscesses
and ultimately in approximately 30–40%, anal fistulas. Additionally, patients with
D. Morte · J. Franko
Department of Surgery, Madigan Army Medical Center, Fort Lewis, WA, USA
S. R. Steele (
Department of Colorectal Surgery, Cleveland Clinic, Cleveland, OH, USA
© Springer Nature Switzerland AG 2022
C. Ratto et al. (eds.), Anal Fistula and Abscess, Coloproctology,
https://doi.org/10.1007/978-3-030-76670-2_31
*)
471

472 D. Morte et al.
Crohn’s disease and in those patients with underlying cancer, radiation, and
obstetrical trauma can develop anal fistulas that can be particularly challenging
to manage. Classification schemes are based on the relationship of the fistula to
the anal sphincter complex. While low-lying intersphincteric and transsphincteric
fistulas are often successfully treated with fistulotomy or setons, recurrent
fistulas require a more varied approach, keeping in mind the delicate balance
between healing and preservation of continence. Choices include seton placement, fibrin glue , collagen plugs, fistulotomy, ligation of intersphincteric tract,
transabdominal approaches, advancement flaps, and episioproctotomy. When
these approaches fail, patients may require more complex procedures to
include muscle interposition flaps. Three of the most commonly used flaps
are the gracilis interposition flap, the Martius flap, and the gluteal fold flap.
The success of these flaps is generally quite high, ranging from 75 to 92% in
some series, while patients with underlying m alignancy, Crohn’sdisease,or
prior radiation are associated with lower rates of 33–66%. In this chapter we
will provide an overview of anal fistulas, briefly describe the options for
treatment, and provide a review of the indications, technique, and results of
these muscle interposition flaps.
1 Introduction
Anal fistu las are a common pathology encountered by healthcare providers.
These fistulas routinely cause significant social and physiologic distress to
patients a nd can often require multiple procedures in an attempt to heal. Most
commonly, anal fistulas develop following anorectal abscesses, but they can also
develop in the setting of Crohn’s disease, cancer, radiation, and trauma. The latter
categories of which are often grouped – along with recurrent fistulas – into
complex fistula s and are associated with lower rates of healing. Rectovaginal
fistulas are a spec ific category of perianal fistula, accounting for <5%, b ut are
notable for a lack of a well-defined strategy for treatment – desp ite a somewhat
wide range of therapeutic options (Tsang and Rothenberger 1997). In gener al,
anorectal fistulas have historically been treated in accordance with the degree of
sphincter involvement, as well as the underlying path ology. Options include
simple drainage, setons, fistulotomy, ligation of intersphincteric tract (LIFT)
procedure, advancement fl aps, muscle transpositions , and resection and pullthrough procedures. The failure rates of these techniques are widely variable,
ranging from 0% to 80% in select studies (Wiskind and Thompson 1992;Gajsek
et al. 2011), though many of these patients may progress on to a suc cessful repair
with repeat procedures (Pinto et al. 2010).
In this chapter, we will provide a brief overview of the pathophysiology and
evaluation of perianal and rectovaginal fistulas and discuss treatment options for
these patients with a specific focus on muscle interposition grafts.

29 Additional Surgical Options to Treat Anal Fistulas: Gracilis... 473
2 Perianal and Rectovaginal Fistulas
2.1 Epidemiology and Diagnosis
Perianal fistulas are an abnormal, epithelialized connection between the rectum or
anus and the perineal skin that typically result from chronic inflammation. A
rectovaginal fistula is a subty pe of these fistulas that develops between the
anorectum and the vagina. Both perianal and rectovaginal fistulas can be emotionally, physically, and socially distressing to patients due to their presence, sequela,
and frequent recurrence despite appropriate treatment. Despite an extensive experience and options, there is no universally accepted treatment algorithm due to
variability in their underlying cause, presentation, degree of symptoms, and location.
One method of stratifying these fistulas is whether they are congenital or
acquired. Congenital fistulas are extremely rare and generally present shortly after
birth, typically in the setting of anorectal atresias or malformations in the genitourinary system. The management of congenital fistulas is generally performed by
specialized pediatric surgeons and beyond the scope of this chapter (Levitt and
Pena 2005; Bailez et al. 2010; Tiwari et al. 2017).
On the contrary, acquired fistulas are much more common in the adult population,
with anorectal abscess as the inciting problem in the vast majority of patients. By this
mechanism, anorectal abscesses develop following blockage of the anal crypts of
Morgagni, leading to infection and inflammation which, depending on the location
of the abscess, will track to either the skin or the vagina. Fistulas develop in around
30–40% of patients with anorectal abscesses and are generally thought to be a
chronic form state of the disease (Bernstein and Schehebar 2020).
Crohn’s disease is another common cause of perianal and rectovaginal fistulas
(Schwartz et al. 2002). Schwartz and colleagues found that 20% of patients with
Crohn’s disease experienced at least one anorectal fistula in a 25-year period and
fistulas accounted for 50–87% of the perianal lesions encountered in Crohn’s
patients. Fistulas are more frequently associated with patients manifesting colitis
versus those with an isolated ileal disease, and their presence placed patients at a
higher risk for recurrent fistula after treatment. Additionally, rectovaginal fistulas
were found to have a prevalence of 10% of women with Crohn’s disease and perianal
complaints (Schwartz et al. 2002; Radcliffe et al. 1988). Unfortunately, perianal
disease in Crohn’s patients tends to portend a much worse prognosis, with a more
potent disease, and medical therapy remains a major part of treatment. More recently,
biological therapy such as infliximab has been demonstrated to have effectively in
Crohn’s perianal disease, though some will require temporary diversion for symptom
control (62%), and a small, yet not insignificant, number, will require either permanent diversion (16%) or even proctectomy (41%) for management of their disease
(Galandiuk et al. 2005).
Malignancy can also lead to fistula formation secondary to the local invasion
through healthy tissues by the tumor. The most common malignancies associated

474 D. Morte et al.
with fistula are vaginal, anal, and rectal cancer. Patients with concern for a possible
malignancy must be carefully and thoroughly evaluated, including tissue diagnosis
and full oncological staging, as a prompt diagnosis is critical appropriate initiation of
treatment and hopefully cure. For those patients with post-therapy recurrence
(i.e., postoperative or following chemo +/ radiation therapy), it is imperative to
determine if the fistula represents a recurrence of the original tumor or other
complication from the surgery, such as an anastomotic leak. With such
distinguishing origins, the treatment options will be widely disparate.
Radiation injury to the rectum (i.e., treatment of prostate cancer) resulting in
chronic radiation proctitis can also lead to the development of perianal fistulas.
These fistulas will generally occur late, around 6–24 months after treatment,
resulting from inflammatory and ulcerative damage secondary to endarteritis
obliterans and tissue hypoxia. Patients with higher doses of radiation and vascular
risk factors to include diabetes, smoking, and hypertension are at increased risk
(Gazala and Wexner 2017). Radiation is also used as a primary treatment modality
for anal cancer, thus not only causing injury to the surrounding tissue that may affect
management options for the fistula, but also highlights the need to rule out recalcitrant or recurrent malignancy.
Trauma, specifically obstetrical trauma, is also a significant risk factor for the
development of rectovaginal fistulas. Obstetric trauma accounts for 80% of acquired
RVF (Senatore Jr 1994). They generally develop after perineal tears that were either
not recognized at the time of injury or had a disrupted repair. Vaginal wall necrosis
from fetal compression or instrumentation can lead to rectovaginal fistulas, as the
septum above the anal sphincter complex is thin (<10 mm). This thin rectovaginal
septum also places patients undergoing colorectal or coloanal anastomoses and
gynecologic surgeries at increased risk for iatrogenic injury, such as the incorporation of the septum into a staple line.
Concern for a perianal fistula should arise in patients with a history of anorectal
abscess that does not heal with time. These patients will typically present with pain,
purulent or bloody discharge, and recurrent abscesses. In the case of rectovaginal
fistulas, patients will describe gas or stool in the vagina, freque nt urinary tract
infections, perianal pain, and dyspareunia. A patient presen ting with these symptoms
should prompt a thorough history with specific attention to their history of cancer,
obstetrical history, concern for Crohn’s disease, continence status, prior anorectal
surgery, prior pelvic radiation, and any history of prior fistulas with subsequent
treatment. It is also important to get an understanding of the impact that this fistula is
having on the patient’s life.
Once the history is complete, the next step is to perform an examination of the
perianal and vaginal region with the goal of localizi ng the fistula. The area will
typically be irritated and inflamed, though small relatively asymptomatic fistulas
may be difficult to find. The external opening may be obvious or palpated as an
indurated region with a concomitant cord. The status of the patient’s anal sphincter
should also be assessed at this time. This examination can be quite uncomfortable for
the patient, and it is recommended that it be performed in the operating room under

29 Additional Surgical Options to Treat Anal Fistulas: Gracilis... 475
anesthesia. This will allow for adequate examination of the perianal region and anal
canal with probing of the fistula.
Advanced imaging can be obtained prior to any exam under anesthesia to assist in
identifying any undraine d abscesses or additional fistulous tracts. Endorectal ultrasound (EUS) is useful in assessing sphincter tone in obstetric patients, as well as
helps identify fistula tracts. Several series have evaluated the utility of EUS with an
injection of H202 to determine not only primary tracks but secondary or “highblind” tracks as well. A history of colon cancer or other concerning history or
symptoms (i.e., bleeding, changes in bowel movements, strong family history)
should trigger a complete colonoscopy. Crohn’s disease patients should be offered
an MR enterography and colonoscopy with ileoscopy to evaluate the large and small
bowel and search for additional lesions. A CT scan is beneficial in postsurgical
patients to evaluate for anastomotic fistulas. MRI and EUS are often the most useful
of these imaging modalities as it specifically pertains to the fistula.
In the operating room, it may still be difficult to identify the fistula. It is important
to avoid probing the tract aggressively and making false passages that may result in
new fistulas. In addition, internal openings may be difficult to identify on the rectal
side with either direct observation or endoscopy. For rectovaginal fistulas, placing a
sterile gauze or “tampon” in the vagina and instilling dilute methylene blue into the
rectum can help identify the presence and/or location of the fistula by seeing blue on
the vaginal gauze. Once the fistula is identified, its location, size, quality of the
surrounding tissue, sphincter involvement, and prior surgical interventions should be
noted and recorded. Any evidence of local sepsis should prompt drainage to allow
for adequate tissue healing prior to definitive intervention, including the use of a
seton or drain. If the patient has a history of radiation, then the rectum should be
evaluated with either rigid or flexible proctoscopy (Hrabe and Hull 2020). Biopsies
can be performed if there is a concern for malignancy, Crohn’s disease, or any other
concerning findings on examination. It is critically important at this stage to take full
note of the integrity of the surrounding tissue. Remember, options for local flaps are
dependent on the quality of this tissue to allow for a successful repair. Active
inflammation, ongoing sepsis, or poor quality will almost guarantee failure even
with a technically proficient operation.
2.2 Classification
The diverse presentation of anorectal fistulas has led to the development of several
classification systems in an attempt to standardize categorization, assist in the
selection of the treatment, predict the relative complexity of the intervention, and
provide an estimate for a successful outcome. Parks et al. developed the most
commonly used classification for anorectal fistulas in 1976. They described four
types of fistulas based on their relationship to the external anal sphincter. Type 1 are
intersphincteric fistulas, which begin at the dentate line and end at the anal verge,
tracking between the internal and external anal sphincters. Type 2 are trans-

476 D. Morte et al.
sphincteric fi stulas that track through the external sphincter into the ischiorectal
fossa and exit in the skin overlying the buttock. Type 3 are suprasphincteric fistulas,
which originate at the anal crypt and circle the entire sphincter complex, terminating
in the ischiorectal fossa. Finally, type 4 are extrasphincteric fistulas that encompass
the entire sphincter muscles to include the levator complex and terminate in the
buttock skin. Fistulas are also divided into low or high fistulas. Low fistulas involve
the distal one-third of the external sphincter while high fistulas involve greater than
half of the external sphincter muscle.
As stated briefly, they can also be classified as either simple or complex. Simple
fistulas are low; have a single external opening, no pain, or fluctuance suggesting an
abscess; are not a rectovaginal fistula; and are not associated with an anorectal
stricture, Crohn’s disease, malignancy, recurrence, or radiation. Complex fistulas
are high, may have multiple external openings, may have pain and fluctuance
suggestive of a concomitant abscess, are rectovaginal in nature, may be associated
with an anorectal stricture, and/or are a result of underlying Crohn’s disease,
radiation, malignancy, or recurrence.
As rectovaginal fistulas are unique and all fall into the criteria of a complex
anorectal fistula, further attempts to dev elop standardized classi fication schemes
have been developed for them. Daniels classified these fistulas based on their
location with low rectovaginal fistulas involving the lower third of the rectum and
the lower half of the vagina, and high rectovaginal fistulas involve the middle third
of the rectum and the upper half of the vagina (Daniels 1949). Rothenberger and
associates further classified rectovagina l fistulas into simple and complex criteria
(1983). Simple rectovaginal fistulas are located in the lower or middle third of the
vagina, result from trauma or infection, and have a diameter 2.5 cm. Complex
rectovaginal fistulas originate in the upper third of the vagina; have a diameter
2.5 cm; occur following inflammatory bowel disease, radiation, or cancer; or
have a history of prior repeated failed repairs. In general, simple fistulas can be
approached with local repairs and are associated with higher rates of successful
healing. On the contrary, complex fistulas often require multiple attempts at repair
due to higher failure rates, and consideration is often given to the need for diversion
and/or secondary flaps to bring healthy tissue into the region.
2.3 Treatment Modalities
Due to the varied presentation of anorectal and rectovaginal fistulas, there is a wide
range of options for their management. The choice of repair depends on the
underlying etiology of the fistula, its location, symptomatology of the fistula,
involved structures, and status of the surrounding tissue. Patients that are minimally
or asymptomatic may decide to forego any surgical intervention. Fistulas resulting
from obstetrical trauma should not be repaired for at least 3 to 6 months, as this will
allow some to heal without intervention (Hrabe and Hull 2020). This delay also
allows for the inflammation of the surrounding structures to resolve and improve the

29 Additional Surgical Options to Treat Anal Fistulas: Gracilis... 477
outcomes of a surgical repair. Patients with fistulas secondary to Crohn ’s disease
should be started on biologic therapy, as this has been shown to resolve nearly 50%
of fistulas (Hrabe and Hull 2020). Any associated abscess should be drained and
allowed a period of time prior to intervention to reduce local sepsis. Furthermore, it
is important to treat any associated proctitis should local tissue flaps (i.e., endorectal
flaps) be considered.
It is important to adhere to four principles when performing fistula surgery:
(1) control the underlying sepsis; (2) define the involved anatomy; (3) treat the
underlying process without compromising sphincter function; and (4) minimize the
risk of recurrence/maximize the chance of success. Most surgeons will elect to
perform a conservative staged approach, with more advanced reconstruction techniques reserved for patients that have recurrences. However, it has been suggested
that this approach could be a cause for the lower effectiveness of more invasive
treatments (Corte et al. 2015). As such, the discussion for the correct choice of
procedure should involve an exhaustive discussion with the patient, reviewing their
options and the risk and benefits associated with each approach.
Biosynthetic materials such as fibrin glue and collagen plugs are easy-to-use
options that induce an inflammatory response leading to the closure of the fistula.
They have the benefit of not risking damage to the sphincter mechanism and being
easily repeatable. Their efficacy is generally poor, around 10–35%, making these
approaches rarely indicated (Gonsalves et al. 2009; Schwandner and Fuerst 2009).
Another biosynthetic material that has shown some promise is the use of biosynthetic mesh placed between the transected fistulous tract. These have been found to
have a low success rate of only 20% for complex fistulas, but further experience with
longer-term follow-up is required to determine their exact place.
Fistulotomy is a commonly used technique with high rates of success for appropriate patients at a low risk for incontinence with superficial, intersphincteric, or low
transsphincteric fistulas (Cologne and Langenfeld 2020). This procedure is
performed by placing the patient in a prone jackknife position with the buttocks
taped apart. Left lateral decubitus and high lithotomy are also acceptable positions,
but exposure is generally improved in the prone jackknife position. The external and
internal openings of the fistula are then identified, and the tract is probed with care
taken to avoid the creation of a false tract. Once the fistula has been cannulated, the
intervening tissue can be divided with the use of electrocautery. The epithelized tract
should be curetted or fulgurated and allowed to heal by secondary intention. Success
rates for this procedure are high, generally >90%, and fecal incontinence secondary
to injury to the anal sphincter should be low when performed in appropriate patients.
A more recent technique developed for the management of transsphincteric
fistulas is the ligation of the intersphincteric fistula tract (LIFT) procedure. This is
generally performed as a staged procedure after maturation of the fistula tract with
the use of a seton . The patient is placed in the prone jackknife position, and the
buttocks are taped apart. The fistula tract is cannulated. A small 1–2 cm incision is
made along the intersphincteric groove, and dissection is continued down to the
fistula tract. A Lone Star retractor (CooperSurgical) can be used to assist with
exposure. The tract is circumferentially dissected, and the probe is removed. Both
Соседние файлы в папке Библиотека им академика М.И. Перельмана
